Subjective Cognitive Decline as a Preclinical Marker for Alzheimer's Disease: The Challenge of Stability Over Time

نویسندگان

  • Marina Ávila-Villanueva
  • Miguel A. Fernández-Blázquez
چکیده

Subjective Cognitive Decline (SCD) refers to a self-experienced persistent decline in cognitive abilities in comparison with a prior normal status and independent of the objective performance on neuropsychological tests (Jessen et al., 2014). It has been proposed that SCDmight appear at the end of the preclinical phase of Alzheimer’s Disease (AD) even in the absence of significant objective impairment detectable on standardized neuropsychological assessment (Rabin et al., 2017). This fact explains why SCD is gaining increased prominence in neurodegenerative research as a potential marker for future Mild Cognitive Impairment (MCI) due to AD. Nevertheless, in our opinion SCD has to face up to a challenge in order to aspire to become a reliable marker of preclinical AD. This challenge is related to the temporal stability of self-reported complaints over time. This manuscript describes this challenge. SCD is considered a sign of preclinical AD that occurs even before objective cognitive impairment appears (Figure 1). A recent meta-analysis has revealed that about 25% of cognitively healthy older adults who report SCDwill developMCI due to AD in the next 4 years (Mitchell et al., 2014). In addition, these individuals have two-fold risk of progression to dementia during a 5-year follow-up period. To increase the potential usefulness of SCD the international working group called Subjective Cognitive Decline Initiative (SCD-I) agreed to a common framework and research procedures to study the role of SCD as a marker of preclinical AD (Jessen et al., 2014). Following these new standards, cognitively healthy individuals who accomplish certain conditions of SCD have been probed to have four times higher risk for developing prodromal AD in just 1-year compared to those subjects without complaints (Fernández-Blázquez et al., 2016). Despite its outstanding clinical value, recently the SCD-I also pointed out some limitations of SCD when it comes to investigating this concept (Rabin et al., 2015; Molinuevo et al., 2017). These limitations could be summarized in three different blocks:

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Reduced Gray Matter Volume in Subjective Cognitive Decline: A Voxel-Based Morphometric Study

Persons with subjective cognitive decline are reported to experience a decline in cognitive capacity without measurable cognitive deficits on objective testing.1 In a meta-analysis, subjective cognitive decline was present in about 17% of healthy elderly.2 The pathophysiological process of Alzheimer’s disease (AD) is thought to begin many years before the diagnosis of AD dementia.3 Subjective c...

متن کامل

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample

INTRODUCTION Subjective cognitive decline (SCD) and biomarker-based "at-risk" concepts such as "preclinical" Alzheimer's disease (AD) have been developed to predict AD dementia before objective cognitive impairment is detectable. We longitudinally evaluated cognitive outcome when using these classifications. METHODS Memory clinic patients (n = 235) were classified as SCD (n = 122): subtle cog...

متن کامل

P 62: Markers of Neuroinflammation Related to Alzheimer\'s Disease Pathology in the Elderly

Alzheimer Disease (AD) is a neurodegenerative disorder and the most common form of dementia. Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunological mechanisms in the brain. In vitro and animal studies have linked neuroinflammation to Alzheimer's disease (AD) pathology. Studies on marke...

متن کامل

Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.

BACKGROUND Subjective cognitive decline (SCD) may result from many conditions, including Alzheimer's disease (AD). OBJECTIVE In this study, we searched for a specific pattern of SCD in asymptomatic individuals at risk for AD. METHODS Cognitively normal older adults (N = 318) reporting SCD and their informants were enrolled in the INSIGHT-PreAD cohort. We examined the relationship between si...

متن کامل

Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?

Background Mild cognitive impairment is considered as the first clinical manifestation of Alzheimer's disease (AD), when the individual exhibits below performance on standardized neuropsychological tests. However, some subjects before having a lower performance on cognitive assessments already have a subjective memory complaint. Objective A review about subjective cognitive decline, the assoc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 9  شماره 

صفحات  -

تاریخ انتشار 2017